These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15457278)

  • 61. Effects of upstream tirofiban versus downstream tirofiban on myocardial damage and 180-day clinical outcomes in high-risk acute coronary syndromes patients undergoing percutaneous coronary interventions.
    Liu T; Xie Y; Zhou YJ; Li YP; Ma HY; Guo YH; Liu YY; Zhao YX; Shi DM
    Chin Med J (Engl); 2009 Aug; 122(15):1732-7. PubMed ID: 19781316
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Elevated CK-MB values after routine angioplasty predicts worse long-term prognosis in low-risk patients.
    Vikenes K; Melberg T; Farstad M; Nordrehaug JE
    Scand Cardiovasc J; 2010 Apr; 44(2):69-75. PubMed ID: 19670037
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prediction of long-term outcome after primary percutaneous coronary intervention for acute anterior myocardial infarction.
    Wita K; Filipecki A; Szydło K; Turski M; Tabor Z; Wróbel W; Elzbieciak M; Lelek M; Bochenek T; Trusz-Gluza M
    Kardiol Pol; 2010 Apr; 68(4):393-400. PubMed ID: 20425697
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA
    Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
    Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
    Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Troponin ratio and risk stratification in subjects with acute coronary syndrome undergoing percutaneous coronary intervention.
    Brunetti ND; Quagliara D; Di Biase M
    Eur J Intern Med; 2008 Oct; 19(6):435-42. PubMed ID: 18848177
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Usefulness of preprocedural serum N-terminal pro-brain natriuretic peptide levels to predict long-term outcome after percutaneous coronary intervention in patients with normal troponin T levels.
    Saleh N; Braunschweig F; Jensen J; Tornvall P
    Am J Cardiol; 2006 Mar; 97(6):830-4. PubMed ID: 16516584
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention.
    Nienhuis MB; Ottervanger JP; Miedema K; Suryapranata H; de Boer MJ; Dambrink JH; Hoorntje JC; van 't Hof AW; Gosselink M; Zijlstra F
    Thromb Haemost; 2006 Feb; 95(2):337-40. PubMed ID: 16493497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relationship of C-reactive protein to adverse cardiovascular events in patients treated by percutaneous coronary intervention for stable angina pectoris.
    Veselka J; Procházková S; Duchonová R; Homolová I; Tesar D
    Int Heart J; 2005 Mar; 46(2):195-204. PubMed ID: 15876803
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome.
    Yee KC; Mukherjee D; Smith DE; Kline-Rogers EM; Fang J; Mehta RH; Almanaseer Y; Akhras E; Cooper JV; Eagle KA
    Am J Cardiol; 2003 Dec; 92(12):1442-4. PubMed ID: 14675582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Troponin I elevation and all-cause mortality after elective percutaneous coronary interventions.
    Ferreira RM; de Souza E Silva NA; Salis LHA; da Silva RRM; Maia PD; Horta LFB; Salles EF; Nunes HMP; de Oliveira JBM; Domingues YPS; de Sousa CCM
    Cardiovasc Revasc Med; 2017 Jun; 18(4):255-260. PubMed ID: 28131744
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention.
    Patti G; Di Sciascio G; D'Ambrosio A; Dicuonzo G; Abbate A; Dobrina A
    Am J Cardiol; 2002 Feb; 89(4):372-6. PubMed ID: 11835913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Liu PY; Li YH; Tsai WC; Chao TH; Tsai LM; Wu HL; Chen JH
    Eur Heart J; 2003 Oct; 24(20):1824-32. PubMed ID: 14563341
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Myocardial damage during percutaneous transluminal coronary angioplasty as evidenced by troponin T measurements.
    Johansen O; Brekke M; Strømme JH; Valen V; Seljeflot I; Skjaeggestad O; Arnesen H
    Eur Heart J; 1998 Jan; 19(1):112-7. PubMed ID: 9503183
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention.
    Dangas G; Mehran R; Feldman D; Stoyioglou A; Pichard AD; Kent KM; Satler LF; Fahy M; Lansky AJ; Stone GW; Leon MB
    Am J Cardiol; 2002 Mar; 89(5):586-9. PubMed ID: 11867045
    [No Abstract]   [Full Text] [Related]  

  • 76. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention.
    Saadeddin SM; Habbab MA; Sobki SH; Ferns GA
    Am J Cardiol; 2002 Apr; 89(8):981-3. PubMed ID: 11950442
    [No Abstract]   [Full Text] [Related]  

  • 77. Troponin I elevation after elective percutaneous coronary interventions: Prevalence and risk factors.
    Ferreira RM; de Souza E Silva NA; Salis LHA; Maia PD; Horta LFB
    Indian Heart J; 2017; 69(3):322-324. PubMed ID: 28648422
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sensitivity and long-term prognostic value of cardiac troponin I increase shortly after percutaneous transluminal coronary angioplasty.
    La Vecchia L
    Clin Cardiol; 1999 Mar; 22(3):252-3. PubMed ID: 10084075
    [No Abstract]   [Full Text] [Related]  

  • 79. Cardiac troponin elevation after elective PCI: adding infarct to major injury.
    Bergmark BA; Morrow DA
    Eur Heart J; 2021 Jan; 42(4):335-338. PubMed ID: 33410468
    [No Abstract]   [Full Text] [Related]  

  • 80. Suppression of Myocardial Injury Markers following Percutaneous Coronary Interventions by Pre-treatment with Carvedilol.
    Moloudi A; Sabzi F; Rashidi S
    Int Cardiovasc Res J; 2012 Sep; 6(3):88-91. PubMed ID: 24757599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.